Table ST2 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma

Table ST2 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma

<p>Table ST2: Summary of the clinical data corresponding to the primary cell cultures used in this publication</p>

Kaydedildi:
Detaylı Bibliyografya
Yazar: Ossia M. Eichhoff (14964145) (author)
Diğer Yazarlar: Corinne I. Stoffel (14964148) (author), Jan Käsler (14964151) (author), Luzia Briker (14964154) (author), Patrick Turko (14964157) (author), Gergely Karsai (14964160) (author), Nina Zila (14964163) (author), Verena Paulitschke (14964166) (author), Phil F. Cheng (14940278) (author), Alexander Leitner (14964169) (author), Andrea Bileck (14964172) (author), Nicola Zamboni (14964175) (author), Anja Irmisch (14964178) (author), Zsolt Balazs (14964181) (author), Aizhan Tastanova (14964184) (author), Susana Pascoal (14964187) (author), Pål Johansen (14964190) (author), Rebekka Wegmann (6698010) (author), Julien Mena (14964193) (author), Alaa Othman (14964196) (author), Vasanthi S. Viswanathan (14964199) (author), Judith Wenzina (14964202) (author), Andrea Aloia (14964205) (author), Annalisa Saltari (14964208) (author), Andreas Dzung (14964211) (author), Michael Krauthammer (14964214) (author), Stuart L. Schreiber (14964217) (author), Thorsten Hornemann (14964220) (author), Martin Distel (14964223) (author), Berend Snijder (14964226) (author), Reinhard Dummer (14850772) (author), Mitchell P. Levesque (14964229) (author)
Baskı/Yayın Bilgisi: 2025
Konular:
Cancer
Tumor Biology
Molecular and Cellular Biology
Therapeutic Research and Development
Drug Resistance
Reversal of drug resistance
Metabolism
Metabolomics
Skin Cancers
Melanoma
Tumor Heterogeneity
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
Diğer Bilgiler
Özet:<p>Table ST2: Summary of the clinical data corresponding to the primary cell cultures used in this publication</p>

Benzer Materyaller